NEURONES |
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| 44.6 EUR | -1.87% |
|
-4.09% | +1.94% |
| Mar. 07 | Neurones: 11% growth in annual net income | CF |
| Mar. 06 | Neurones S.A. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
Strengths
- Thanks to a sound financial situation, the firm has significant leeway for investment.
- The group usually releases upbeat results with huge surprise rates.
Weaknesses
- As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
- The company appears highly valued given the size of its balance sheet.
- The average consensus view of analysts covering the stock has deteriorated over the past four months.
- Over the past twelve months, analysts' opinions have been revised negatively.
Ratings chart - Surperformance
Sector: IT Services & Consulting
| 1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
|---|---|---|---|---|
| +1.94% | 1.16B | - | ||
| -14.25% | 189B | A- | ||
| +0.72% | 166B | B+ | ||
| +1.62% | 152B | B- | ||
| +3.83% | 99.37B | A- | ||
| +5.76% | 77.36B | A- | ||
| +14.58% | 70.76B | C- | ||
| -7.93% | 70.46B | A | ||
| -22.01% | 51.83B | C | ||
| -6.79% | 44.34B | A- |
Investor Rating
Trading Rating
ESG Refinitiv
-
Financials
Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances
Valuation
P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
-
Yield
Momentum
1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision
Consensus
Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion
Business Predictability
Analyst Coverage
Divergence of Estimates
-
Divergence of analysts' opinions
-
Divergence of Target Price
-
Earnings quality
Technical analysis
ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
- Stock Market
- Equities
- NRO Stock
- Ratings NEURONES
